Lyon/Montreal/Brussels/Paris, may 17, 2017 : Editions Européennes of Innovation, a multimedia company which deploys in the written press under the brand BIOTECHFINANCES, (n° 1 of the weekly French-speaking specialized in the life sciences), datamining under the brand BioMap France, BioMap Quebec and for audio-visual platform EEI-Biotechfinances.com announce the recruitment of a new editor-in-chief, Mr. Pierre-Louis Germain.
Boost your gains
Jacques-Bernard Taste, president and director of the publication of BIOTECHFINANCES said : “I am very pleased to announce the next arrival, on June 19, Pierre-Louis Germain, who will take over the editor-in-chief of BIOTECHFINANCES. His journalistic experience is established, their perfect knowledge of the actors of the sector and its expertise in financial matters will allow BIOTECHFINANCES to develop its business strategy and accelerate the implementation of its business plan. This strategy has the heart the strengthening of our position as a leader in the specialty media in the life sciences in all the French-speaking world and within international networks, using French as the language of business. This deployment will be formalized by the historic return of BIOTECHFINANCES to Paris (after a lapse of 10 years) where our presence is warmly solicited by the professionals in life sciences who have been following us for the past 18 years “.
Mr. Pierre-Louis Germain, editor-in-chief
Pierre-Louis Germain will be in charge of the development of the editorial line of BIOTECHFINANCES in consultation with the editorial committee of international Editions of European Innovation, of the steering and drafting of the editorial products of which the principal purpose of the weekly BIOTECHFINANCES and its variations web.
Pierre-Louis Germain, 37 years old, is an economic journalist, press card n°110630. It covers since 2008 the news of the biotech and medtech French as a journalist and chief of heading for the weekly Income and as a columnist for BFM Business. He is the author of the book “Investing in biotech” (editions Maxima, 2016), a book of reference on the biotechnology sector in France.
About BIOTECHFINANCES
EEI BIOTECHFINANCES, founded in 2005, is a multimedia company, which deploys in the written press under the brand BIOTECHFINANCES, n° 1 of the weekly French-speaking specialized in the life sciences, datamining under the brand BioMap France BioMap Quebec and for audio-visual platform EEI-Biotechfinances.com. The weekly BIOTECHFINANCES was first launched in 1999 within the group of the daily newspaper Les Echos before being purchased by Jacques-Bernard Taste in 2005. The mission of Biotech Finances is to federate and to inform the international community of francophone and francophile life sciences with a single media dedicated to the economy, finance and business development. At the heart of all the international networks promoting French as the language of business, the teams BIOTECHFINANCES include 7 professional journalist and a columnist, 30 expert contributors francophone distributed in 12 countries. BIOTECHFINANCES target the French-speaking area (33 countries), la francophonie ((80 States and governments are members or observers of the OIF), the francophone working in groups, ETI, SMES and international associations, circles and francophone organizations in the world
For more information, visit our website : http://www.eei-biotechfinances.com/
Follow us on twitter : @biotech_finance
The French in the world
The community of bioentrepreneurs, scientists, and business people, francophones and francophiles is active across the globe.
· French is one of the 4 languages important trade practiced in the world.
· French is now the 2nd language of business in Europe.
· First spoken language in the world in 2050 (220 M in 2012 / 750 M by 2050);
· Sharing the same mother tongue increases of over 30%, the likelihood of commercial success when the two protagonists work in different countries.
Boost your gains